191 related articles for article (PubMed ID: 20041222)
1. Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.
Li S; Floess S; Hamann A; Gaudieri S; Lucas A; Hellard M; Roberts S; Paukovic G; Plebanski M; Loveland BE; Aitken C; Barry S; Schofield L; Gowans EJ
PLoS Pathog; 2009 Dec; 5(12):e1000707. PubMed ID: 20041222
[TBL] [Abstract][Full Text] [Related]
2. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
Li S; Jones KL; Woollard DJ; Dromey J; Paukovics G; Plebanski M; Gowans EJ
Immunol Cell Biol; 2007; 85(3):197-204. PubMed ID: 17199111
[TBL] [Abstract][Full Text] [Related]
3. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
Itose I; Kanto T; Kakita N; Takebe S; Inoue M; Higashitani K; Miyazaki M; Miyatake H; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2009 Dec; 16(12):844-52. PubMed ID: 19486278
[TBL] [Abstract][Full Text] [Related]
4. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
5. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.
Ebinuma H; Nakamoto N; Li Y; Price DA; Gostick E; Levine BL; Tobias J; Kwok WW; Chang KM
J Virol; 2008 May; 82(10):5043-53. PubMed ID: 18337568
[TBL] [Abstract][Full Text] [Related]
6. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients.
Losikoff PT; Mishra S; Terry F; Gutierrez A; Ardito MT; Fast L; Nevola M; Martin WD; Bailey-Kellogg C; De Groot AS; Gregory SH
J Hepatol; 2015 Jan; 62(1):48-55. PubMed ID: 25157982
[TBL] [Abstract][Full Text] [Related]
7. F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hashempour T; Bamdad T; Bergamini A; Lavergne JP; Haj-Sheykholeslami A; Brakier-Gingras L; Ajorloo M; Merat S
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25862675
[TBL] [Abstract][Full Text] [Related]
8. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
9. CD26: a negative selection marker for human Treg cells.
Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
[TBL] [Abstract][Full Text] [Related]
10. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
[TBL] [Abstract][Full Text] [Related]
11. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia?
Steinborn A; Haensch GM; Mahnke K; Schmitt E; Toermer A; Meuer S; Sohn C
Clin Immunol; 2008 Dec; 129(3):401-12. PubMed ID: 18805741
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
13. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
Xu D; Fu J; Jin L; Zhang H; Zhou C; Zou Z; Zhao JM; Zhang B; Shi M; Ding X; Tang Z; Fu YX; Wang FS
J Immunol; 2006 Jul; 177(1):739-47. PubMed ID: 16785573
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
15. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
16. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
Franceschini D; Paroli M; Francavilla V; Videtta M; Morrone S; Labbadia G; Cerino A; Mondelli MU; Barnaba V
J Clin Invest; 2009 Mar; 119(3):551-64. PubMed ID: 19229109
[TBL] [Abstract][Full Text] [Related]
18. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
19. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
